How much is Izana Bioscience worth in 2026?

Izana Bioscience has a current valuation of N/A based on their Buyout/LBO (Add-on)† round and secondary market data.

How much funding has Izana Bioscience raised?

Izana Bioscience has raised N/A in total funding across 1 funding rounds.

Izana Bioscience

Biotechnology

Izana Bioscience valuation and funding history | Last updated: July 20, 2020 | 1 funding rounds

Current Valuation

N/A

As of July 20, 2020

Total Funding Raised

N/A

Across 1 round

Last Round

Buyout/LBO (Add-on)†

Amount undisclosed

Last Funding

Jul 2020

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
July 20, 2020	Buyout/LBO (Add-on)†	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Izana Bioscience is currently valued at N/A as of July 20, 2020.

Track Izana Bioscience Valuation Updates

Get notified when Izana Bioscience raises new funding or valuation changes

Explore More Data

Detailed analysis for Izana Bioscience

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Izana Bioscience's valuation history, funding rounds, and growth metrics.

No credit card required

What is Izana Bioscience Worth in 2026?

Izana Bioscience is a leading private company in the Biotechnology sector. Track Izana Bioscience's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Izana Bioscience Valuation is Determined

Private company valuations like Izana Bioscience's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.